These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3301490)

  • 21. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease.
    Crimi E; Orefice U; De Benedetto F; Grassi V; Brusasco V
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):501-8. PubMed ID: 7788518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
    Dal Negro R; Turco P; Pomari C; Monici-Preti P
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
    Middleton E
    Ann Allergy; 1981 Nov; 47(5 Pt 2):427-8. PubMed ID: 6795977
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic non-compliance in patients with chronic airway obstruction].
    Barrueco M; Otero MJ; Fernández de Gatta MR; Martín J; de Portugal J; Domínguez-Gil A
    Rev Clin Esp; 1987 Apr; 180(6):293-5. PubMed ID: 3602534
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy using delayed-action theophylline].
    Ulmer WT; Zimmermann I
    Fortschr Med; 1982 Nov; 100(42):1973-6. PubMed ID: 7152431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Improvement of ventilation in patients with restrictive and irreversible obstructive ventilation disorders by a single dose of theophylline].
    Radenbach D; Gatzemeier U; Schulz HU
    Prax Klin Pneumol; 1985 May; 39(5):159-61. PubMed ID: 4022928
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-pharmacologic possibilities of theophylline therapy].
    Dzúrik R; Zverková D; Spustová V; Gajdos M
    Vnitr Lek; 1987 Jun; 33(6):440-7. PubMed ID: 3660689
    [No Abstract]   [Full Text] [Related]  

  • 35. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL; Alexander MR
    Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 21-day double-blind study of the effect of adding sustained-release theophylline (Nuelin SA) to inhaled salbutamol in patients with asthma.
    Sahay JN; Chatterjee SS
    Br J Dis Chest; 1983 Jan; 77(1):66-70. PubMed ID: 6344899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 39. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 40. [Principles of theophylline therapy in obstructive respiratory diseases].
    Ukena D; Sybrecht GW
    Pneumologie; 1992 Feb; 46(2):49-51. PubMed ID: 1549553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.